{"id":42306,"date":"2024-01-24T14:53:57","date_gmt":"2024-01-24T14:53:57","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=42306"},"modified":"2024-01-24T14:53:57","modified_gmt":"2024-01-24T14:53:57","slug":"could-combining-two-drugs-be-better-for-treating-prostate-cancer","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/could-combining-two-drugs-be-better-for-treating-prostate-cancer\/42306\/","title":{"rendered":"Could combining two drugs be better for treating prostate cancer?"},"content":{"rendered":"
A Phase 3 clinical trial led by UC San Francisco researchers discovered that combining testosterone-blocking drugs in patients with prostate cancer relapse is better at treating prostate cancer than treatment with a single drug.<\/h2>\n
Prostate cancer treatment is usually carried out with one of several testosterone-lowering drugs for a set period of time.<\/p>\n